Human heparanase-1 gene expression in pancreatic adenocarcinoma

Journal of Gastrointestinal Surgery

Volumn 6, Issue 2, 2002, Pages 167-172

  Kim, Anthony W ^a   Xu, Xiulong ^a   Hollinger, Edward F ^a   Gattuso, Paolo ^a   Godellas, Constantine V ^a   Prinz, Richard A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Heparanase 1; Metastis; Pancreatic cancer; Survival

Indexed keywords

HEPARANASE; HEPARANASE 1; UNCLASSIFIED DRUG; BETA GLUCURONIDASE;

ADULT; AGE; AGED; ARTICLE; AUTOPSY; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ASSAY; FEMALE; FREQUENCY ANALYSIS; GENE EXPRESSION; HEALTH STATUS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MALE; PANCREAS ADENOCARCINOMA; PANCREAS CELL; PANCREAS DUCT; PREDICTION; SAMPLE; SEX; ADENOCARCINOMA; COMPARATIVE STUDY; CULTURE TECHNIQUE; ENZYMOLOGY; GENETIC MARKER; GENETICS; METABOLISM; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; PREDICTION AND FORECASTING; PROBABILITY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CULTURE TECHNIQUES; FEMALE; GENE EXPRESSION; GENETIC MARKERS; GLUCURONIDASE; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 0036518867     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(01)00087-7     Document Type: Article

References (23)

1. Hulett M, Freeman C, Hamdorf B, Baker R, Harris M, Parish C. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med 1999;5:803-809.
2. McKenzie E, Tyson K, Stamps A, Smith P, Turner P, Barry R, Hircock M, Patel S, Barry E, Stubberfield C, Terrett J, Page M. Cloning and expression profiling of hpa2, a novel mammalian heparanase family member. Biochem Biophys Res Commun 2000;276:1170-1177.
3. Vlodavsky I, Freidmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R, Bitan M, Pappo O, Peretz T, Michal I, Spector L, Pecker I. Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis. Nat Med 1999;5:793-802.
4. Nakajima M, Irimura T, Nicolson G. Heparanases and tumor metastasis. Cell Biochem 1988;36:157-167.
5. Friedmann Y, Vlodavsky I, Aingorn H, Aviv A, Peretz T, Pecker I, Pappo O. Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma: Evidence for its role in colonic tumorigenesis. Am J Pathol 2000;157:1167-1175.
6. Nakajima M, DeChavigny A, Johnson CE, Hamada J, Stein CA, Nicolson GL. Suramin. A potent inhibitor of melanoma heparanase and invasion. J Biol Chem 1991;266:9661-9666.
7. Parish CR, Freeman C, Brown KJ, Francis DJ, Cowden WB. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity. Cancer Res 1999;59:3433-3441.
8. Eccles S. Heparanase: Breaking down barriers in tumors. Nat Med 1999;5:735-736.
9. Jin L, Nakajima M, Nicolson GL. Immunochemical localization of heparanase in mouse and human melanomas. Int J Cancer 1990;45:1088-1095.
10. Kussie PH, Hulmes JD, Ludwig DL, Patel S, Navarro EC, Seddon AP, Giorgio NA, Bohlen P. Cloning and functional expression of a human heparanase gene. Biochem Biophys Res Commun 1999;261:183-187.
11. Hruban RH, van Mansfeld AD, Offerhaus GJ, van Weering DH, Allison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, Bos JL. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993;143:545-554.
12. Wanebo HJ, Vezeridis MP. Pancreatic carcinoma in perspective. A continuing challenge. Cancer 1996;78:580-591.
13. Schwarz LC, Inoue T, Irimura T, Damen JE, Greenberg AH, Wright JA. Relationships between heparanase activity and increasing metastatic potential of fibroblasts transfected with various oncogenes. Cancer Lett 1990;51:187-192.
14. Marchetti D, McQuillan D, Spohn W, Carson D, Nicolson G. Neurotrophin stimulation of human melonamo cell invasion: Selected enhancement of heparanse activity and heparanase degradation of specific heparan sulfate subpopulations. Cancer Res 1996;56:2856-2863.
15. Zhu ZW, Friess H, Wang L, Bogardus T, Korc M, Kleeff J, Buchler MW. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells. Clin Cancer Res 2001;7:105-112.
16. Andela VB, Schwarz KM, Puzas JE, O'Keefe RJ, Rosier RN. Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappaB. Cancer Res 2000;60:6557-6562.
17. Dempsey LA, Plummer TB, Coombes SL, Platt JL. Heparanase expression in invasive trophoblasts and acute vascular damage. Glycobiology 2000;10:467-475.
18. Ihrcke NS, Parker W, Reissner KJ, Platt JL. Regulation of platelet heparanase during inflammation: Role of pH and proteinases. J Cell Physiol 1998;175:255-267.
19. Marchetti D, Menter D, Jin L, Nakajima M, Nicolson GL. Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production. Int J Cancer 1993;55:692-699.
20. Irimura T, Nakajima M, Nicolson GL. Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells. Biochemistry 1986;25:5322-5328.
21. Miao HQ, Elkin M, Aingorn E, Ishai-Michaeli R, Stein CA, Vlodavsky I. Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides. Int J Cancer 1999;83:424-431.
22. Parish CR, Coombe DR, Jakobsen KB, Underwood PA. Evidence that sulphated polysaccharides inhibit tumor metastasis by blocking tumor cell-derived heparanase. Int J Cancer 1987;40:511-517.
23. Koliopanos A, Friess H, Kleeff J, Shi X, Liao Q, Pecker I, Vlodavsky I, Zimmermann A, Buchler MW. Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res 2001;61:4655-4659.